# Commission Implementing Decision of 26 April 2011 allowing Member States to extend provisional authorisations granted for the new active substances ascorbic acid, ipconazole, spiromesifen, topramezone, and Pseudomonas sp. strain DSMZ 13134 (notified under document C(2011) 2668) (Text with EEA relevance) (2011/252/EU) (revoked), Introduction: Introductory text

Extent: E+W+S+N.I.

Commission Implementing Decision
of 26 April 2011
allowing Member States to extend provisional authorisations granted for the new active substances ascorbic acid, ipconazole, spiromesifen, topramezone, and Pseudomonas sp. strain DSMZ 13134
(notified under document C(2011) 2668)
(Text with EEA relevance)
(2011/252/EU) (revoked)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/eudn/2011/252/introduction (the official version)
Page: https://openlegislation.uk/eu-decision-2011-252/introduction
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.